Top compounds associated with response to AGRN


Feature Type Standardized
Nominal ANOVA
mRNA tanespimycin:bortezomib (250:1 mol/mol) CTRPv2 pan-cancer AAC -0.15 0.001
mRNA manumycin A CTRPv2 pan-cancer AAC -0.13 0.001
mRNA ML203 CTRPv2 pan-cancer AAC -0.15 0.002
mRNA neopeltolide CTRPv2 pan-cancer AAC -0.27 0.002
mRNA BRD4132 CTRPv2 pan-cancer AAC -0.14 0.002
mRNA BRD9876 CTRPv2 pan-cancer AAC -0.14 0.002
mRNA Midostaurin GDSC1000 pan-cancer AAC 0.11 0.002
mRNA necrosulfonamide CTRPv2 pan-cancer AAC -0.15 0.002
mRNA AT7867 CTRPv2 pan-cancer AAC -0.13 0.002
mRNA navitoclax:sorafenib (1:1 mol/mol) CTRPv2 pan-cancer AAC -0.13 0.002
Download CSV